Based on our advanced algorithm, we predict that RNA stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $29.23, while the 1-week outlook suggests a value of $29.77. For the 1-month forecast, we project a price of $30.19. Looking further ahead, our 2026 projection estimates a value of $0.00, with a long-term 2030 forecast reaching $0.00. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RNA has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
RNA stock price ended at $28.8 on Monday, after losing-1.27%
The Avidity Biosciences Inc stock price decreased by -1.27% on the last trading day (07 Jul 2025), dropping from 28.89 to 28.8. Throughout the last trading session, the stock experienced a fluctuation of 4.68% , ranging from a day low of $27.98 to a day high of 29.29. The price has declined in 6 of the last 10 days, resulting in a total change of -1.74% during this period. On the last day, trading volume increase by 729.08K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.28M shares were traded, amounting to approximately 36.30M.
RNA Technical Signals
RNA(Avidity Biosciences Inc Corp) has 0 buy signals and 4 sell signals now. The current trend is uptrend starting from 2025-07-01. The total price change during this trend is +1.19%. Recently, the price has decreased with an increase in volume, indicating a strong bearish signal. The average turnover of RNA over the last 5 trading days is 27.47M. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
RNA Moving Average Analysis
Avidity Biosciences Inc's overall moving average trend leans more bearish as of Tuesday, July 8, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $30.88, and $31.96. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $27.40, and $26.33. A break-down below any of these levels will issue sell signals.
RNA Short Selling Analysis
The short sale ratio of Avidity Biosciences Inc(RNA) as of 03 Jul 2025 is 23.05%, dropping from last trading day. With decreasing price from 29.36 to 29.17. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Sell
4
Buy
0
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
0 Bullish Signals
0 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
No Data
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, Avidity Biosciences Inc (RNA) is anticipated to change hands in a trading channel between $0.00 and $0.00.
Avidity Biosciences Inc Stock Forecast 2026
RNA Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Avidity Biosciences Inc(RNA), our algorithm predicts RNA's 1-month price at $35.58, with an 21.99%upwardshift. Using a similarity score up to 96.34%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Avidity Biosciences Inc (RNA.O) stock, as of Sunday, July 6, 2025 , forecasts a 21.99% change over the next month, based on its high correlation with XOS.O stock patterns. The similarity between their price movements over the analyzed periods is 96.34%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
RNA
No Data
XOS
Up: 21.99%Similarity: 96.34%
Name
Similarity
Up/Down
XOS.O
96.34%
+21.99%
ASYS.O
95.49%
-2.10%
LITB.N
95.42%
+3.19%
ALEC.O
95.41%
-12.79%
LIXT.O
95.35%
+43.14%
RXRX.O
95.29%
-13.93%
LOT.O
95.21%
-13.40%
STKS.O
95.07%
-7.72%
INDP.O
95.05%
-14.75%
MIDD.O
94.86%
+0.96%
RNA Seasonality Analysis
Based on RNA's historical stock price data across all years, the probability of a positive return in July is60.00%, suggesting it maybe an ideal month to invest in RNA. In contrast,Juneoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Avidity Biosciences Inc (RNA.O) stock in June has the highest probability of a positive return (80.00%), while October has the lowest probability (0.00%).
Performance Seasonality
The chart shows Avidity Biosciences Inc. (RNA)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Avidity Biosciences Inc (RNA.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RNA has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Avidity Biosciences Inc (RNA.O) stock in a year?
The radar chart shows that buying Avidity Biosciences Inc (RNA.O) stock in June has the highest probability of a positive return (80.00%), while October has the lowest probability (0.00%).
How has Avidity Biosciences Inc. (RNA)'s stock price performed over the past three years?
RNA's stock price fell by -55.31% in 2023,increased by 217.47% in 2024, and went down by 7.63%in 2025.
Is RNA a buy based on overall technical signals summary?
RNA has 0 buy signals and 4 sell signals now. Overall the technical rating for RNA is Strong sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of RNA.
What is the trend of Avidity Biosciences Inc (RNA)'s moving average?
Avidity Biosciences Inc's overall moving average trend leans more bearish as of July 08 2025, with 3 negative signals and 1 positive signal.
What is price prediction for RNA stock next month?
The price prediction chart for Avidity Biosciences Inc (RNA.O) stock, as of July 06 2025, forecasts a 21.99% change over the next month, based on its high correlation with XOS stock patterns. The similarity between their price movements over the analyzed periods is 96.34%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for RNA Stock?
### **Price Prediction for RNA Stock in 2025**
Based on current trends and analysis, RNA stock is expected to trade between **$32 and $38** in the short term. The stock shows potential for moderate growth due to its position in the growing nucleotide drug market, but volatility and overbought conditions may lead to a pullback.
**Reasons for the Prediction:**
1. **Technical Indicators**: RNA's RSI_14 is at 69.07, indicating a neutral position, while the Stochastic Oscillator is overbought at 91.63, suggesting a potential pullback.
2. **Market Volatility**: The stock has shown significant price swings, with recent highs of $38 and lows of $30.90, reflecting high volatility in the biopharma sector.
3. **Sector Trends**: The nucleotide drug market is growing, with companies like Ribo Life and TransCode Therapeutics advancing their pipelines, which could impact RNA's performance.
4. **Valuation Risks**: RNA's forward P/E ratio is negative, indicating potential overvaluation and investor uncertainty.
What is price prediction 2030 for RNA Stock?
### **Price Prediction for RNA Stock by 2030**
RNA stock is predicted to reach **$50 by 2030**, driven by its strong pipeline of siRNA drugs and partnerships. The stock is currently overbought, with RSI at 83.36 and near Bollinger Bands upper limit, suggesting a potential pullback. However, the growing RNA therapy market and potential successful trials position RNA for long-term growth.